| Catalog No | Package | Original Price | Price | Inventory | Quantity | Operating |
|---|---|---|---|---|---|---|
| BP4176-5mg | 5mg | $190.00 | Sign in |
|
Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
55.7600
4.5310
4.5291
.0256
4.6601
4.2357
High
91.9708
2.2523
Yes
Yes
Yes
No
No
No
0.0
No
No
No
Yes
Capsiate ester (CAS No.: 205687-01-0) is a natural product derived from plants of the Capsilocus genus and is an analogue of capsaicin. Compared to capsaicin, capsaicin esters have the notable characteristic of being non-irritating, which has attracted widespread attention in food science, pharmacology, and functional nutrition. Capsaicin ester was originally isolated from the CH-19 non-irritating sweet red chili pepper variety. As an orally active TRPV1 receptor agonist, it exhibits multiple biological activities, including analgesic, antioxidant, hypoglycemic, anti-inflammatory, and angiogenesis inhibition. In recent years, with in-depth research into the TRPV1 channel and its related signaling pathways, capsaicin ester has become one of the hot topics in natural product pharmacology research due to its good safety and potential clinical applications.
This paper will systematically review the chemical structure and physicochemical properties of capsaicin ester, plant origin and extraction methods, pharmacological activity and mechanism of action, druggability evaluation and pharmacokinetic characteristics, and, combined with its potential applications in analgesic and metabolic diseases, explore its future clinical development prospects and challenges.
The chemical name of capsaicin ester is (6E)-8-methylnon-6-enoic acid and carboxylate ester of vanillol, with a molecular formula of C19H30O4 and a molecular weight of 306.4020. Its structural feature is that capsiate acid and vanillin alcohol are linked by ester bonds to form monomethoxybenzene compounds, belonging to the phenolic compound family. Unlike capsaicin, the ester bonds in capsaicin esters make it difficult for free capsaicin to be released in the mouth and gastrointestinal tract, thus showing non-irritating properties.
In terms of physicochemical properties, the LogP value of capsaicin ester is 4.5310, indicating high lipid solubility, which facilitates cell membrane penetration and oral absorption. Its topological polar surface area (TPSA) is 55.76 Ų, indicating moderate polarity and favorable binding to biomacromolecules. Its low water solubility (0.0256 mg/mL) suggests limited solubility in the aqueous phase, but its high lipid solubility and low polarity make it easy to cross the blood-brain barrier (BBB), providing a molecular basis for its pharmacological role in the central nervous system. The hERG channel inhibition test was negative, indicating a low risk of cardiotoxicity. The Ames mutagenic test result was 0.0, indicating low genotoxicity risk and good safety.
Capsaicin esters are mainly found in Capsicum plants, especially the CH-19 sweet red chili (Capsicum annuum L.) variety. Due to its unique genetic background, this variety contains almost no irritant capsaicin, but is rich in capsaicin. The fruit ripening period of this plant is the optimal window for collection and extraction.
The extraction process usually uses solvent extraction, with commonly used organic solvents including ethanol, methanol, and ethyl acetate. During extraction, temperature and pH must be controlled to prevent hydrolysis of capsaicin esters. Modern extraction technologies such as ultrasonic-assisted extraction, microwave-assisted extraction, and supercritical fluid extraction have been applied to the efficient extraction of capsaicin esters, significantly improving yield and purity.
The crude extract is separated and purified using column chromatography, high-performance liquid chromatography (HPLC), and other methods to obtain high-purity capsaicin esters. Identification methods mainly include mass spectrometry (MS), nuclear magnetic resonance (NMR), and infrared spectroscopy (IR), ensuring the exact structural accuracy of the compounds.
The pharmacological activity of capsaicin ester covers a variety of physiological and pathological processes, mainly including the following aspects:
Capsaicin esters, as an agonist of the TRPV1 receptor, can modulate pain perception. TRPV1 channels are expressed in sensory neurons and mediate pain signal transduction caused by thermal and chemical stimuli. Capsaicin ester activates TRPV1, inducing calcium ion influx, thereby regulating neuronal excitability and demonstrating analgesic effects. Compared to capsaicin, capsaicin esters are non-irritating, suitable for oral administration, and have better tolerability.
In addition, capsaicin ester also affects other related targets such as CNR1 (cannabinoid receptor 1), OPRD1 (δ-opioid receptor), OPRM1 (μ-opioid receptor), and participates in the multi-target synergistic effect of pain regulation, enhancing its analgesic effect.
Capsaicin esters have significant antioxidant activity, capable of scavenging free radicals and reducing oxidative stress. Its phenolic structure gives it excellent free radical capture ability, lowers intracellular ROS levels, and protects cells from oxidative damage.
In the inflammation model, capsaicin ester reduces inflammatory responses by inhibiting the expression of inflammatory mediators such as PTGS1 (COX-1) and PTGS2 (COX-2). Additionally, it can inhibit TRPA1 channels, reducing inflammation-related neural excitability and further exerting anti-inflammatory effects.
Capsaicin ester activates the TRPV1 channel, promotes energy metabolism and fat oxidation, improves insulin sensitivity, and shows blood sugar-lowering effects. Animal experiments have shown that capsaicin esters can lower blood sugar levels and improve disorders of glycolipid metabolism, offering potential value in treating type 2 diabetes.
The inhibitory effect of capsaicin ester in angiogenesis may be achieved by regulating vascular endothelial cell function and related signaling pathways, demonstrating its potential value in tumors and neovascular diseases.
In addition, capsaicin ester exhibits anti-allergic activity, which may be related to regulating immune cell function and inhibiting the release of allergic mediators, making it promising as an adjunct treatment for allergic diseases.
The biological effects of capsaicin ester are mainly realized through its activation of the TRPV1 receptor. TRPV1 is a non-selective cation channel widely distributed in sensory neurons and various tissue cells, participating in various physiological processes such as pain, inflammation, and metabolic regulation.
After capsaicin ester binds to TRPV1, it induces channel opening, triggering calcium ion influx and activating downstream signaling pathways including calcium-dependent protein kinase (CaMK), protein kinase C (PKC), and MAPK pathways, regulating gene expression and cell function. Additionally, capsaicin ester affects neurotransmitter receptors such as CNR1, OPRD1, OPRM1, and OPRK1, modulating nerve conduction and pain perception.
In inflammation regulation, capsaicin ester reduces prostaglandin synthesis and lowers the release of inflammatory mediators by inhibiting PTGS1 and PTGS2 expression. At the same time, it inhibits TRPA1 channels, reducing inflammation-related neural excitability and pain.
Its hypoglycemic effect may involve promoting the function of pancreatic islet β cells, enhancing insulin secretion and sensitivity, regulating fatty acid metabolism, promoting fat oxidation, and reducing metabolic stress.
In summary, capsaicin ester achieves diverse pharmacological effects through multi-target and multi-pathway synergistic effects.
The druggability parameters of capsaicin ester indicate that it has promising potential for drug development. Its molecular weight is 306.4, meeting the Lipinski rule, with a LogP of 4.53, indicating moderate lipid solubility, which is beneficial for membrane permeability and oral absorption. TPSA is 55.76 Ų, making it suitable for binding with biomacromolecules to support their biological activity.
Low water solubility (0.0256 mg/mL) is a major challenge in formulation development, requiring improved bioavailability through technologies such as nanocarriers, solid dispersions, or liposomes. Capsaicin ester can effectively cross the blood-brain barrier, suggesting its potential application in central nervous system diseases.
In terms of safety, the hERG channel inhibition test was negative, reducing the risk of cardiotoxicity. The Ames test result was 0, indicating no significant mutagenicity and good safety.
Pharmacokinetic studies show that capsaicin esters are rapidly absorbed orally and have higher bioavailability than capsaicin. Due to their ester bond structure, they can be hydrolyzed by esterases in the body, releasing active ingredients and exerting their efficacy. Its metabolism mainly passes through liver enzyme systems, with excretion primarily through bile and urine. The half-life is moderate, which helps maintain stable plasma concentrations.
Capsaicin ester has broad clinical application potential due to its non-irritating properties, high safety, and multiple pharmacological activities. Its analgesic effect makes it a novel candidate drug for managing chronic pain, neuropathic pain, and inflammatory pain. Compared to traditional capsaicin, capsaicin esters are better orally tolerated and suitable for long-term use.
In the field of metabolic diseases, capsaicin ester shows potential in treating type 2 diabetes and obesity by regulating energy metabolism and insulin sensitivity. Its antioxidant and anti-inflammatory effects help alleviate chronic inflammatory conditions associated with metabolic syndrome.
In addition, the angiogenesis inhibitory and anti-allergic effects of capsaicin ester offer new therapeutic approaches for tumor therapy and allergic diseases.
Future research should focus on clinical trial designs for capsaicin esters, clarifying its effective dose, safe dose range, and long-term safety assessment. At the same time, optimizing formulation technology and improving its water solubility and bioavailability will be key to advancing its clinical application.
As a natural product, capsaicin ester shows broad prospects for drug development thanks to its unique chemical structure and multi-target, multi-mechanism pharmacological activity. Its non-irritating and excellent safety advantages make it highly valuable for pain relief, metabolic diseases, and inflammation-related treatments. In the future, through in-depth mechanistic research and clinical validation, capsaicin ester is expected to become a major breakthrough in the field of natural product pharmacology, providing new strategies and options for the treatment of related diseases.
